SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-125336
Filing Date
2023-12-12
Accepted
2023-12-12 15:30:39
Documents
16
Period of Report
2023-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332569d1_8k.htm   iXBRL 8-K 29755
2 EXHIBIT 10.1 tm2332569d1_ex10-1.htm EX-10.1 14314
3 EXHIBIT 10.2 tm2332569d1_ex10-2.htm EX-10.2 81634
4 EXHIBIT 10.3 tm2332569d1_ex10-3.htm EX-10.3 17075
5 EXHIBIT 10.4 tm2332569d1_ex10-4.htm EX-10.4 14104
  Complete submission text file 0001104659-23-125336.txt   355096

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gdnsf-20230607.xsd EX-101.SCH 3036
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE gdnsf-20230607_lab.xml EX-101.LAB 34240
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gdnsf-20230607_pre.xml EX-101.PRE 22372
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2332569d1_8k_htm.xml XML 3054
Mailing Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402
Business Address 207 SOUTH 9TH STREET MINNEAPOLIS MN 55402 604-617-5421
Goodness Growth Holdings, Inc. (Filer) CIK: 0001771706 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56225 | Film No.: 231481058
SIC: 2834 Pharmaceutical Preparations